Loading
Impact Biomedical Inc. Stock: price and insider trades · United States
US·Mcap US$29.1M
No insider purchase over the last 90 days. The latest was filed 09 Dec 2024.
Impact Biomedical Inc.: what insiders have been doing
Impact Biomedical Inc. is a listed company. Its insiders report their share dealings to SEC (Form 4). In the past year (18 October 2025 to 18 October 2026), 5 filings came from 3 insiders.
Only sales appear on the open market, 5 sales in all totalling €30k, filed by 3 insiders. One trade stands out by size: a sale of €28k from Grady Jason, disclosed on 25 March 2026.
Compared with its exchange (5,808 companies, median 19 filings), a count of 5 filings is below the norm. Since 2024, the database holds 5 purchases and 14 sales by insiders of the company.
The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
Other companies in the same market with recent insider buying flagged by our signals: GameStop Corp. and Heico Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
19
Thresholds
n/a
Buy Volume
€126,646
5 ops. · all time
Sell Volume
€2M
14 ops. · all time
Who traded when
BuySaleDSS, Inc.10 sales
Frank D. Heuszel3 buys
Heng Fai Ambrose Chan3 sales
Jason Grady1 sale
Todd D. Macko1 sale
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$3.40
Analyst consensus
Income statement
RevenueUS$32k
Gross profit-US$392k-1225% margin
EBITDA-US$12.5M-39100% margin
Net income-US$11.8M2260.0% margin
Valuation
PER (trailing)0.4x
P/Book2.7x
Beta2.73
Balance sheet & cash
Market capUS$29.1M
Total debtUS$8.9M
Free Cash Flow-US$1.9M
Debt / Equity9%
Profitability & ownership
ROE23.5%
ROA-17.8%
% insiders89.0%
% institutions3.6%
Last declaration on 24 September 2026
Declarations19 total
1,600 shares@ US$0.6008100.0% of flowCommon StockSEC:0001493152-26-013708:0
50,000 shares@ US$0.6501100.0% of flowCommon StockSEC:0001493152-26-012746:0
351,555 shares@ US$0.49526.2% of flowCommon stockSEC:0001641172-25-003021:0
300,000 shares@ US$0.58126.5% of flowCommon stockSEC:0001641172-25-002819:0
300,000 shares@ US$1.02847.3% of flowCommon StockSEC:0001641172-25-002479:0
500 shares@ US$2.257829.0% of flowCommon StockSEC:0001493152-24-049260:0
Canonical exit: 5 Mar 2025 (T+90)
550 shares@ US$2.62537.4% of flowCommon StockSEC:0001493152-24-048576:0
Canonical exit: 24 Feb 2025 (T+90)
500 shares@ US$2.6133.6% of flowCommon StockSEC:0001493152-24-048579:0
Canonical exit: 25 Feb 2025 (T+90)
19 of 19 declarations
About Impact Biomedical Inc.
Impact Biomedical Inc. is a company focused on developing innovative biomedical solutions. It is listed on the XNAS market.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
